Jeddah Health Cluster 2 signed a cooperation agreement with Jamjoom Pharma, one of the leading Saudi companies in pharmaceutical healthcare in the Middle East and Africa region, aiming to strengthen cooperation in health fields, raise awareness of diseases, and develop healthcare cadres’ scientific knowledge of modern medicines, alongside exchanging expertise in a way that contributes to improving the quality of healthcare.
The agreement includes implementing awareness and educational programs, organizing scientific and training activities, and exchanging expertise across various medical specialties, supporting the professional development of healthcare practitioners and enhancing the adoption of best practices based on scientific evidence.
The Cluster affirmed that this agreement comes within the framework of strengthening partnerships with the health sector, contributing to developing national competencies and supporting initiatives that elevate the quality of health services and create added value for beneficiaries.
The agreement aligns with Jeddah Health Cluster 2’s strategic objectives of improving the quality of health services, empowering healthcare cadres, and strengthening strategic partnerships, through developing knowledge and skills, exchanging expertise, and providing higher-quality health services to beneficiaries.
This cooperation also supports the objectives of Saudi Vision 2030 aimed at developing the health sector, raising the efficiency of services, and improving quality of life.
The agreement was signed by Dr. Essam Gameel Al Sayed, General Manager at Jamjoom Pharma Saudi Arabia, and Dr. Shadi bin Salem Al Khayyat, Chief Executive Officer of Jeddah Health Cluster 2, in the presence of a number of representatives from both sides.
Dr. Essam Gameel Al Sayed, General Manager at Jamjoom Pharma Saudi Arabia and representative of this cooperation, said: “This partnership reflects the importance of integration between the public and private sectors in supporting health awareness and developing medical knowledge, contributing to the transfer of specialized expertise and enhancing the quality of health services in line with the best modern practices.”
“He also affirmed that, through this cooperation, Jamjoom Pharma continues to expand its contributions to supporting health and educational initiatives in the Kingdom, and to consolidate its role as an effective partner in developing the health sector by building sustainable cooperation with various health institutions, offering an effective model for integration between the public and private sectors.”
-End-
